Press
Releases

Press Releases

March 25, 2020
Altimmune to Announce Year End 2019 Financial Results on March 27
GAITHERSBURG, Md. , March 25, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report financial results for the year ended December 31, 2019 and host a conference call on Friday, March 27, 2020 .
February 19, 2020
Altimmune to Present at the Cowen 40th Annual Health Care Conference
GAITHERSBURG, Md. , Feb. 19, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Vipin K. Garg , Ph.D., President and Chief Executive Officer will present at the Cowen 40 th Annual Health Care Conference in Boston on Monday, March
February 4, 2020
Altimmune to Present at Upcoming Investor and Scientific Conferences
GAITHERSBURG, Md. , Feb. 04, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that management will present at the following conferences during the months of February:     2020 BIO CEO & Investor Conference Date:    Monday, February
January 7, 2020
Altimmune to Present at the 2020 NASH-TAG Conference
GAITHERSBURG, Md. , Jan. 07, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced an oral presentation at the 2020 NASH-TAG Conference being held on January 9-11, 2020 in Park City, Utah.  Details for the oral presentation are as
 

Investor Contact

Ashley Robinson
LifeSci Advisors, LLC

Email: arr@lifesciadvisors.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe